stars 1 stars 2 stars 3

Medendi gives patients a deep understanding of their specific tumor profile and identifies and advises the most effective targeted treatment options available, including worldwide clinical trials, when appropriate. The Medendi process is totally online, paperless, and quick. In one month from on boarding the patient will be advised with the best available treatment options, provided by the most qualified health structures network. The Journey. Analysis: an expert, from the Medendi Scientific Committee, analyzes the patient’s clinical documentation and evaluates whether genomic profiling is needed or, alternatively, the patient would benefit from a second opinion. Genetic Testing: to identify the best available treatment, the tumor is profiled with the most advanced genetic tests to scan for tumor genomic alterations. Recommendation: the expert advises the patient with the best therapeutic options available worldwide, including molecules and drugs in clinical trial; Medendi, thanks to its global network and online DBs, is up to date with the most qualified medical centers, the new drugs and molecules researched and the ongoing clinical trials. Treatment: Medendi supports the patients in the therapy phase: accessing the selected medical center and the best specialists, providing the most appropriate treatment, managing documentation, and eventually supporting the patient and the family for trip and accommodation.

Medendi Questions

The Medendi annual revenue was $4 million in 2026.

1 people are employed at Medendi.

Medendi is based in Modena, Emilia-Romagna.

The NAICS codes for Medendi are [62, 622, 622310, 6223, 62231].

The SIC codes for Medendi are [806, 80].

G2 Leader Summer 2026 G2 Best Est ROI Mid-Market Summer 2026 G2 Easiest Admin Mid-Market Summer 2026 G2 Most Implementable Summer 2026 G2 Best Results Mid-Market Summer 2026 G2 Lead Capture Mid-Market Summer 2026 Inc Fastest Growing Private Companies 2026 Inc Best Workplace 2026
g2crowd
G2Crowd Trusted
chromestore
300K+ Plugin Users